Study protocol of a randomized controlled trial to assess safety of teleconsultation compared with face-to-face consultation: the ECASeT study

BackgroundThe use of remote consultation modalities has exponentially grown in the past few years, particularly since the onset of the COVID-19 pandemic. Although a huge body of the literature has described the use of phone (tele) and video consultations, very few of the studies correspond to random...

ver descrição completa

Detalhes bibliográficos
Autores: Rodríguez Molinero, Alejandro, Carot Sans, Gerard, Escrig, Roser, Tebé, Cristian, Arce, Jacobo, Pérez López, Carlos, Ballesta, Silvia, Verdejo, Guillermo, Cedeño, Ángel, Riera Pagespetit, Mar, Vivas Angeles, Sofia, Alarcon, Jose L., Navarro, Itziar, Toro, Silvia, Mateo, Llorenç, Torres, Ana J., Delmás, Gerard, Camell, Helena, Chamero, Antonio, Gasol, Montse, Piera Jiménez, Jordi, Benaiges, David, Tikhomirova, Lidia, Torrente, Vicenç, Marimón, Jesús, Saavedra Pérez, David, Menendez, Violeta, Franquet, Elisabet, Sierra, Luis M., López Diéguez, María, Rodríguez, Nuria, Gonzales, Jessica, Macho Pérez, Oscar, Huguet, Sandra, Degano, Lucas, Pineda, Francisco, Errando, Javier, Ecaset Research Group
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2023
País:España
Recursos:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/206223
Acesso em linha:https://hdl.handle.net/2445/206223
Access Level:acceso abierto
Palavra-chave:SARS-CoV-2
Espanya
Spain
id ES_603e27b7aa07ec71024acaa7574dfb02
oai_identifier_str oai:recercat.cat:2445/206223
network_acronym_str ES
network_name_str España
repository_id_str
spelling Study protocol of a randomized controlled trial to assess safety of teleconsultation compared with face-to-face consultation: the ECASeT studyRodríguez Molinero, AlejandroCarot Sans, GerardEscrig, RoserTebé, CristianArce, JacoboPérez López, CarlosBallesta, SilviaVerdejo, GuillermoCedeño, ÁngelRiera Pagespetit, MarVivas Angeles, SofiaAlarcon, Jose L.Navarro, ItziarToro, SilviaMateo, LlorençTorres, Ana J.Delmás, GerardCamell, HelenaChamero, AntonioGasol, MontsePiera Jiménez, JordiBenaiges, DavidTikhomirova, LidiaTorrente, VicençMarimón, JesúsSaavedra Pérez, DavidMenendez, VioletaFranquet, ElisabetSierra, Luis M.López Diéguez, MaríaRodríguez, NuriaGonzales, JessicaMacho Pérez, OscarHuguet, SandraDegano, LucasPineda, FranciscoErrando, JavierEcaset Research GroupSARS-CoV-2EspanyaSARS-CoV-2SpainBackgroundThe use of remote consultation modalities has exponentially grown in the past few years, particularly since the onset of the COVID-19 pandemic. Although a huge body of the literature has described the use of phone (tele) and video consultations, very few of the studies correspond to randomized controlled trials, and none of them has assessed the safety of these consultation modalities as the primary objective. The primary objective of this trial was to assess the safety of remote consultations (both video and teleconsultation) in the follow-up of patients in the hospital setting.MethodsMulticenter, randomized controlled trial being conducted in four centers of an administrative healthcare area in Catalonia (North-East Spain). Participants will be screened from all individuals, irrespective of age and sex, who require follow-up in outpatient consultations of any of the departments involved in the study. Eligibility criteria have been established based on the local guidelines for screening patients for remote consultation. Participants will be randomly allocated into one of the two study arms: conventional face-to-face consultation (control) and remote consultation, either teleconsultation or video consultation (intervention). Routine follow-up visits will be scheduled at a frequency determined by the physician based on the diagnostic and therapy of the baseline disease (the one triggering enrollment). The primary outcome will be the number of adverse reactions and complications related to the baseline disease. Secondary outcomes will include non-scheduled visits and hospitalizations, as well as usability features of remote consultations. All data will either be recorded in an electronic clinical report form or retrieved from local electronic health records. Based on the complications and adverse reaction rates reported in the literature, we established a target sample size of 1068 participants per arm. Recruitment started in May 2022 and is expected to end in May 2024.DiscussionThe scarcity of precedents on the assessment of remote consultation modalities using randomized controlled designs challenges making design decisions, including recruitment, selection criteria, and outcome definition, which are discussed in the manuscript.Trial registrationNCT05094180. The items of the WHO checklist for trial registration are available in Additional file 1. Registered on 24 November 2021.Springer Science and Business Media LLC2024202420232024info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion11 p.application/pdfhttps://hdl.handle.net/2445/206223Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a: https://doi.org/10.1186/s13063-023-07679-1Trials, 2023, vol. 24, num. 1https://doi.org/10.1186/s13063-023-07679-1cc by (c) Rodríguez Molinero, Alejandro et al., 2023http://creativecommons.org/licenses/by/3.0/es/info:eu-repo/semantics/openAccessoai:recercat.cat:2445/2062232026-05-29T05:05:01Z
dc.title.none.fl_str_mv Study protocol of a randomized controlled trial to assess safety of teleconsultation compared with face-to-face consultation: the ECASeT study
title Study protocol of a randomized controlled trial to assess safety of teleconsultation compared with face-to-face consultation: the ECASeT study
spellingShingle Study protocol of a randomized controlled trial to assess safety of teleconsultation compared with face-to-face consultation: the ECASeT study
Rodríguez Molinero, Alejandro
SARS-CoV-2
Espanya
SARS-CoV-2
Spain
title_short Study protocol of a randomized controlled trial to assess safety of teleconsultation compared with face-to-face consultation: the ECASeT study
title_full Study protocol of a randomized controlled trial to assess safety of teleconsultation compared with face-to-face consultation: the ECASeT study
title_fullStr Study protocol of a randomized controlled trial to assess safety of teleconsultation compared with face-to-face consultation: the ECASeT study
title_full_unstemmed Study protocol of a randomized controlled trial to assess safety of teleconsultation compared with face-to-face consultation: the ECASeT study
title_sort Study protocol of a randomized controlled trial to assess safety of teleconsultation compared with face-to-face consultation: the ECASeT study
dc.creator.none.fl_str_mv Rodríguez Molinero, Alejandro
Carot Sans, Gerard
Escrig, Roser
Tebé, Cristian
Arce, Jacobo
Pérez López, Carlos
Ballesta, Silvia
Verdejo, Guillermo
Cedeño, Ángel
Riera Pagespetit, Mar
Vivas Angeles, Sofia
Alarcon, Jose L.
Navarro, Itziar
Toro, Silvia
Mateo, Llorenç
Torres, Ana J.
Delmás, Gerard
Camell, Helena
Chamero, Antonio
Gasol, Montse
Piera Jiménez, Jordi
Benaiges, David
Tikhomirova, Lidia
Torrente, Vicenç
Marimón, Jesús
Saavedra Pérez, David
Menendez, Violeta
Franquet, Elisabet
Sierra, Luis M.
López Diéguez, María
Rodríguez, Nuria
Gonzales, Jessica
Macho Pérez, Oscar
Huguet, Sandra
Degano, Lucas
Pineda, Francisco
Errando, Javier
Ecaset Research Group
author Rodríguez Molinero, Alejandro
author_facet Rodríguez Molinero, Alejandro
Carot Sans, Gerard
Escrig, Roser
Tebé, Cristian
Arce, Jacobo
Pérez López, Carlos
Ballesta, Silvia
Verdejo, Guillermo
Cedeño, Ángel
Riera Pagespetit, Mar
Vivas Angeles, Sofia
Alarcon, Jose L.
Navarro, Itziar
Toro, Silvia
Mateo, Llorenç
Torres, Ana J.
Delmás, Gerard
Camell, Helena
Chamero, Antonio
Gasol, Montse
Piera Jiménez, Jordi
Benaiges, David
Tikhomirova, Lidia
Torrente, Vicenç
Marimón, Jesús
Saavedra Pérez, David
Menendez, Violeta
Franquet, Elisabet
Sierra, Luis M.
López Diéguez, María
Rodríguez, Nuria
Gonzales, Jessica
Macho Pérez, Oscar
Huguet, Sandra
Degano, Lucas
Pineda, Francisco
Errando, Javier
Ecaset Research Group
author_role author
author2 Carot Sans, Gerard
Escrig, Roser
Tebé, Cristian
Arce, Jacobo
Pérez López, Carlos
Ballesta, Silvia
Verdejo, Guillermo
Cedeño, Ángel
Riera Pagespetit, Mar
Vivas Angeles, Sofia
Alarcon, Jose L.
Navarro, Itziar
Toro, Silvia
Mateo, Llorenç
Torres, Ana J.
Delmás, Gerard
Camell, Helena
Chamero, Antonio
Gasol, Montse
Piera Jiménez, Jordi
Benaiges, David
Tikhomirova, Lidia
Torrente, Vicenç
Marimón, Jesús
Saavedra Pérez, David
Menendez, Violeta
Franquet, Elisabet
Sierra, Luis M.
López Diéguez, María
Rodríguez, Nuria
Gonzales, Jessica
Macho Pérez, Oscar
Huguet, Sandra
Degano, Lucas
Pineda, Francisco
Errando, Javier
Ecaset Research Group
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv SARS-CoV-2
Espanya
SARS-CoV-2
Spain
topic SARS-CoV-2
Espanya
SARS-CoV-2
Spain
description BackgroundThe use of remote consultation modalities has exponentially grown in the past few years, particularly since the onset of the COVID-19 pandemic. Although a huge body of the literature has described the use of phone (tele) and video consultations, very few of the studies correspond to randomized controlled trials, and none of them has assessed the safety of these consultation modalities as the primary objective. The primary objective of this trial was to assess the safety of remote consultations (both video and teleconsultation) in the follow-up of patients in the hospital setting.MethodsMulticenter, randomized controlled trial being conducted in four centers of an administrative healthcare area in Catalonia (North-East Spain). Participants will be screened from all individuals, irrespective of age and sex, who require follow-up in outpatient consultations of any of the departments involved in the study. Eligibility criteria have been established based on the local guidelines for screening patients for remote consultation. Participants will be randomly allocated into one of the two study arms: conventional face-to-face consultation (control) and remote consultation, either teleconsultation or video consultation (intervention). Routine follow-up visits will be scheduled at a frequency determined by the physician based on the diagnostic and therapy of the baseline disease (the one triggering enrollment). The primary outcome will be the number of adverse reactions and complications related to the baseline disease. Secondary outcomes will include non-scheduled visits and hospitalizations, as well as usability features of remote consultations. All data will either be recorded in an electronic clinical report form or retrieved from local electronic health records. Based on the complications and adverse reaction rates reported in the literature, we established a target sample size of 1068 participants per arm. Recruitment started in May 2022 and is expected to end in May 2024.DiscussionThe scarcity of precedents on the assessment of remote consultation modalities using randomized controlled designs challenges making design decisions, including recruitment, selection criteria, and outcome definition, which are discussed in the manuscript.Trial registrationNCT05094180. The items of the WHO checklist for trial registration are available in Additional file 1. Registered on 24 November 2021.
publishDate 2023
dc.date.none.fl_str_mv 2023
2024
2024
2024
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/206223
url https://hdl.handle.net/2445/206223
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://doi.org/10.1186/s13063-023-07679-1
Trials, 2023, vol. 24, num. 1
https://doi.org/10.1186/s13063-023-07679-1
dc.rights.none.fl_str_mv cc by (c) Rodríguez Molinero, Alejandro et al., 2023
http://creativecommons.org/licenses/by/3.0/es/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc by (c) Rodríguez Molinero, Alejandro et al., 2023
http://creativecommons.org/licenses/by/3.0/es/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 11 p.
application/pdf
dc.publisher.none.fl_str_mv Springer Science and Business Media LLC
publisher.none.fl_str_mv Springer Science and Business Media LLC
dc.source.none.fl_str_mv Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869409290538713088
score 15,812455